Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migrationAlja Zottel, Radovan Komel, Neja Šamec et al.|Therapeutic Advances in Medical Oncology|2020Cited by 41